TrendFlares logo

Lineage Cell Therapeutics, Inc. (LCTX)

$0.91 3.41% $0.03 Healthcare

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers Renevia, a facial aesthetics product. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.

$171.84M

Mr. Brian M. Culley M.A., M.B.A.

57.00

Carlsbad, CA

Mar 05, 1992

-7.00

$-0.13

1.94

2.64

-391.00%

-7.11

-0.25

2.52

27.81

2.64

-23.53%

-35.54%

Downtrend

Similar stocks (16)

Replimune Group, Inc.

REPL

$11.23 1.35%
Uptrend

Nuvation Bio Inc.

NUVB

$2.95 1.72%
Neutral

Gossamer Bio, Inc.

GOSS

$0.96 5.35%
Downtrend

Coherus BioSciences, Inc.

CHRS

$1.13 7.62%
Downtrend

Nuvectis Pharma, Inc.

NVCT

$6.75 0.75%
Downtrend

Ovid Therapeutics Inc.

OVID

$1.17 10.38%
Downtrend

Armata Pharmaceuticals, Inc.

ARMP

$2.23 6.19%
Downtrend

Spero Therapeutics, Inc.

SPRO

$1.36 1.12%
Downtrend

MAIA Biotechnology, Inc.

MAIA

$2.85 1.79%
Neutral

Kronos Bio, Inc.

KRON

$0.95 2.99%
Downtrend

NextCure, Inc.

NXTC

$1.43 2.14%
Downtrend

ImmuCell Corporation

ICCC

$3.63 0.83%
Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.63 1.35%
Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.67%
Downtrend

Cadrenal Therapeutics, Inc.

CVKD

$11.21 -6.43%
Neutral

Portage Biotech Inc.

PRTG

$10.21 3.03%
Downtrend

ETF Exposure (19)

iShares Micro-Cap ETF

IWC

0.03504%

$126.54 2.19%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$208.30 2.26%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$90.58 2.07%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.00997%

$285.77 2.18%
Uptrend

iShares Russell 2000 ETF

IWM

0.00487%

$223.97 2.06%
Uptrend

ProShares Ultra Russell2000

UWM

0.0019060705486212914%

$44.09 4.26%
Uptrend

ProShares UltraPro Russell2000

URTY

9.395857335337295e-4%

$54.27 6.25%
Uptrend

ProShares Hedge Replication ETF

HDG

7.974459326559405e-4%

$50.07 0.41%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$253.06 1.86%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend